News Home

Where Does Wall Street Think VBI Vaccines Inc (VBIV) Stock Will Go?

Wednesday, December 09, 2020 01:13 PM | InvestorsObserver Analysts
Where Does Wall Street Think VBI Vaccines Inc (VBIV) Stock Will Go?

Analysts who follow VBI Vaccines Inc (VBIV) on average expect it to gain 179.61% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.

That average rating earns the stock an Analyst Ranking of 79, which means it ranks higher than 79 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 5
Wall Street analysts are rating VBIV a Strong Buy today. Find out what this means to you and get the rest of the rankings on VBIV!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.

InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With VBI Vaccines Inc Stock Today?

VBI Vaccines Inc (VBIV) stock is trading at $3.04 as of 1:11 PM on Wednesday, Dec 9, a loss of -$0.23, or -7.19% from the previous closing price of $3.27. The stock has traded between $3.01 and $3.30 so far today. Volume today is low. So far 2,940,106 shares have traded compared to average volume of 6,923,036 shares.

Click Here to get the full report on VBI Vaccines Inc (VBIV) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App